MedCity NewsReport: Sean Parker and Peter Thiel back cancer immunotherapy startup 3T BiosciencesMedCity NewsOne year after setting up a $250 million institute devoted to cancer immunotherapy, Sean Parker has backed 3T Biosciences alongside fellow billi… Continue reading
New York Times |
In a First, Gene Therapy Halts a Fatal Brain Disease
New York Times For the first time, doctors have used gene therapy to stave off a fatal degenerative brain disease, an achievement that some experts had thought impossible. The key to making the therapy work? One of the medicine’s greatest villains: HIV. The patients … |
|
Broad Researchers Develop Pooled Genomic Perturbation Screening Method Using CRISPR
GenomeWeb “Specifically, we will screen pooled genomic perturbations (with barcoded CRISPR-Cas9 single guide RNAs) using microscopy to read out phenotypes and to identify perturbed genes at the single-cell level,” they wrote in the abstract. “Perturbed genes … |
MIT Technology Review |
Arming Bodies with CRISPR to Fight Huntington’s Disease and ALS
MIT Technology Review To do it, Gene Yeo, the company’s cofounder and a professor of cellular and molecular medicine at the University of California, San Diego, School of Medicine, is repurposing CRISPR to go after a different target: RNA, the messenger molecule involved in … |